We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$115B
1-Year Est. Return
41.58%
This Fund
S&P 500
This Quarter
Est. Return
-5.54%
1 Year Est. Return
+41.58%
3 Year Est. Return
+119.77%
5 Year Est. Return
+143.7%
10 Year Est. Return
+448.76%
AUM
$79.9B
AUM Growth
-$6.45B
(-7.5%)
Cap. Flow
-$1.92B
Cap. Flow
% of AUM
-2.4%
Top 10 Holdings %
Top 10 Hldgs %
28.59%
Holding
1,534
New
77
Increased
494
Reduced
709
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$128M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$124M |
| 3 |
Broadridge
BR
|
+$105M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$101M |
| 5 |
Motorola Solutions
MSI
|
+$94.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlassian
TEAM
|
+$332M |
| 2 |
NVIDIA
NVDA
|
+$268M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$190M |
| 4 |
TSMC
TSM
|
+$149M |
| 5 |
Cisco
CSCO
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.97% |
| 2 | Technology | 17.33% |
| 3 | Healthcare | 10.95% |
| 4 | Consumer Discretionary | 9% |
| 5 | Industrials | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Hudbay
HBM
$10.4B
| $2.4M | ﹤0.01% |
596,454
-19,802
| -3% | -$79.3K |
|
952
National Bank Holdings
NBHC
$1.92B
| $2.35M | ﹤0.01% |
63,200
-12,900
| -17% | -$518K |
|
953
NRG Energy
NRG
$29.2B
| $2.35M | ﹤0.01% |
59,978
-400
| -0.7% | -$16K |
|
|
SAGE
954
DELISTED
Sage Therapeutics
SAGE
| $2.35M | ﹤0.01% |
59,355
+400
| +0.7% | +$15.5K |
|
955
Henry Schein
HSIC
$9.85B
| $2.35M | ﹤0.01% |
35,279
+24
| +0.1% | +$1.78K |
|
956
Huntington Ingalls Industries
HII
$12.8B
| $2.33M | ﹤0.01% |
10,420
-40
| -0.4% | -$8.97K |
|
|
ONC
957
BeOne Medicines Ltd
ONC
$32.6B
| $2.31M | ﹤0.01% |
16,981
-1,339
| -7% | -$230K |
|
958
Molson Coors Class B
TAP
$7.86B
| $2.31M | ﹤0.01% |
47,927
+600
| +1% | +$32.5K |
|
959
Qiagen
QGEN
$8.73B
| $2.31M | ﹤0.01% |
52,798
-2,477
| -4% | -$122K |
|
|
RAPT
960
DELISTED
RAPT Therapeutics
RAPT
| $2.3M | ﹤0.01% |
12,042
| – | – |
|
961
Celestica
CLS
$39.3B
| $2.3M | ﹤0.01% |
272,198
-534,628
| -66% | -$5.42M |
|
|
XIFR
962
XPLR Infrastructure LP
XIFR
$1.12B
| $2.27M | ﹤0.01% |
30,980
-2,096
| -6% | -$168K |
|
963
Caesars Entertainment
CZR
$6.06B
| $2.27M | ﹤0.01% |
69,853
+430
| +0.6% | +$18.7K |
|
964
First Financial Bankshares
FFIN
$5.08B
| $2.26M | ﹤0.01% |
53,500
+42,100
| +369% | +$1.81M |
|
965
RBC Bearings
RBC
$18.1B
| $2.25M | ﹤0.01% |
10,696
-466
| -4% | -$107K |
|
|
GORV
966
DELISTED
Lazydays
GORV
| $2.25M | ﹤0.01% |
5,723
| – | – |
|
967
BorgWarner
BWA
$13B
| $2.25M | ﹤0.01% |
80,639
-227
| -0.3% | -$7.32K |
|
|
RNAM
968
DELISTED
Avidity Biosciences
RNAM
| $2.23M | ﹤0.01% |
133,271
+800
| +0.6% | +$15.3K |
|
|
GTM
969
ZoomInfo Technologies
GTM
$1.05B
| $2.23M | ﹤0.01% |
53,445
-7,844
| -13% | -$333K |
|
970
Constellium
CSTM
$3.85B
| $2.21M | ﹤0.01% |
213,138
-13,018
| -6% | -$173K |
|
|
NEX
971
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $2.21M | ﹤0.01% |
299,210
-9,476
| -3% | -$83K |
|
972
Novanta
NOVT
$5.28B
| $2.19M | ﹤0.01% |
18,476
-25,860
| -58% | -$3.52M |
|
|
MRTX
973
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.18M | ﹤0.01% |
31,135
| – | – |
|
974
Payoneer
PAYO
$2.4B
| $2.18M | ﹤0.01% |
370,468
+123,800
| +50% | +$719K |
|
|
JNPR
975
DELISTED
Juniper Networks
JNPR
| $2.16M | ﹤0.01% |
82,863
-300
| -0.4% | -$8.46K |
|
Similar funds
VAM
TD Asset Management's Q3 2022 Portfolio in Review
As of Q3 2022, TD Asset Management held 1,534 positions worth $79.9B, down 7.5% from $86.3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
TD Asset Management's Q3 2022 filing shows 77 new, 494 increased, 709 reduced and 60 closed positions. Its largest new stake was Eagle Materials: 154,517 shares worth $16.4M. The largest sale was Atlassian, an estimated $332M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.
- TD Asset Management's largest Q3 2022 buy was Eagle Materials: 154,517 shares worth $16.4M.
- TD Asset Management added most to Thermo Fisher Scientific in Q3 2022, an estimated $128M increase.
- TD Asset Management's biggest Q3 2022 reduction was NVIDIA, cutting an estimated $268M.
- TD Asset Management fully exited Atlassian in Q3 2022, selling an estimated $332M.
- TD Asset Management's ten largest holdings make up 29% of its $79.9B portfolio in Q3 2022.
- TD Asset Management opened 77 new positions and closed 60 in Q3 2022.
- TD Asset Management's portfolio value fell 7.5% quarter-over-quarter to $79.9B.
Based on TD Asset Management's 13F filing for Q3 2022, filed 7 Nov 2022.